GW PHARMACEUTICALS PLC Accumulated Other Comprehensive Income
GW PHARMACEUTICALS PLC had Accumulated Other Comprehensive Income of -$51.02 million as of 2021-03-31, per its 10-Q filed 2021-05-03.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2021-05-03
- 2021-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$51.02M.
- 2020-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$53.55M.
- 2020-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$71.42M.
- 2020-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$84.39M.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2021-03-31 | -$51.02M 10-Q · filed 2021-05-03 |
| 2020-12-31 | -$53.55M 10-Q · filed 2021-05-03 |
| 2020-09-30 | -$71.42M 10-Q · filed 2020-11-05 |
| 2020-06-30 | -$84.39M 10-Q · filed 2020-08-07 |
| 2020-03-31 | -$83.05M 10-Q · filed 2020-05-11 |
| 2019-12-31 | -$68.62M 10-K · filed 2021-02-26 |
| 2019-09-30 | -$87.55M 10-Q · filed 2019-11-06 |
| 2019-06-30 | -$79.77M 10-Q · filed 2019-08-07 |
| 2019-03-31 | -$74.89M 10-Q · filed 2019-05-08 |
| 2018-12-31 | -$78.69M 10-K · filed 2020-02-27 |
| 2018-09-30 | -$75.19M 10-KT · filed 2019-02-28 |
| 2017-09-30 | -$74.52M 10-KT · filed 2019-02-28 |